William Blair & Company
NMTC icon

William Blair & Company’s NeuroOne Medical Technologies NMTC Stock Holding History

William Blair & Company’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,009
Closed -$36.4K – 1982
2025
Q4 		$36.4K Sell
8,009
-1,250
-14% -$5.69K ﹤0.01% 1686
2025
Q3 		$49.4K Hold
9,259
– – ﹤0.01% 1644
2025
Q2 		$37.7K Hold
9,259
– – ﹤0.01% 1631
2025
Q1 		$47.2K Hold
9,259
– – ﹤0.01% 1597
2024
Q4 		$45.9K Hold
9,259
– – ﹤0.01% 1621
2024
Q3 		$55K Buy
+9,259
New +$46.3K ﹤0.01% 1616

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

William Blair & Company's NMTC Position: Q1 2026 in Review

William Blair & Company sold out of NeuroOne Medical Technologies (NMTC) in Q1 2026, closing a stake of 8,009 shares — an estimated $36.4K sold.

William Blair & Company first reported a position in NMTC in Q3 2024 and held it in 6 quarters. The position peaked at $55K in Q3 2024. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • William Blair & Company reported no remaining NeuroOne Medical Technologies position as of Q1 2026 after selling out during the quarter.
  • William Blair & Company sold 8,009 NeuroOne Medical Technologies shares in Q1 2026, an estimated $36.4K.
  • William Blair & Company first reported a position in NeuroOne Medical Technologies in Q3 2024 and held it in 6 quarters.
  • William Blair & Company's NeuroOne Medical Technologies position peaked at $55K in Q3 2024.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.